糖尿病患者白内障超声乳化吸出人工晶状体植入疗效分析  

Phacoemulsification with intraocular lens implantation in diabetic patients

作　　者：陈华洁[1] 沈念慈[1] 朱力[1] 王燕[1] 张小兰[1] 吴磊[1] 

机构地区：[1]中国上海华东医院眼科,200040

出　　处：《国际眼科杂志》2004年第2期329-331,共3页International Eye Science

摘　　要：目的:探讨糖尿病患者白内障超声乳化吸出(phaco)及人工晶状体(IOL)植入的手术效果。方法:对46例(56眼)糖尿病患者行白内障超声乳化吸出人工晶状体植入术,观察术中、术后并发症及术后视力的情况。结果:术后视力≥0.5者46眼(82.1%),术后并发症:角膜内皮水肿、前房纤维渗出、人工晶状体表面色素沉着、后囊膜混浊,与同期非糖尿病患者比较差异无显著性。结论:对于糖尿病患者只要术前血糖控制在相对稳定的水平上进行白内障超声乳化吸出及人工晶状体植入术疗效是安全有效的,术后并发症少,视力恢复好。AIM: To study the effect of phacoemulsification with intraocular lens implantation in diabetic patients.· MEHTODS: A total of 56 eyes of 46 diabetics underwent phaco and IOL implantation. Postoperative complications and visual acuity were observed.· RESULTS: Postoperative visual acuity was 0.5 or higher in 46 eyes (82.1%). Postoperative complications included edema of cornea endothelium, inflammation of interior chamber, pigment deposits on the surface of IOL and posterior capsule opacity. There was no significant difference compared with non-diabetic patients.· CONCLUSION: Phaco and IOL implantation can be performed in diabetics when their blood glucose are controlled at a relative stable level, and the result is safe and effective.·

关 键 词：糖尿病 白内障 超声乳化吸出术 人工晶状体植入术 临床疗效 术后并发症 

分 类 号：R779.66[医药卫生—眼科]